MSFT   207.28 (+1.26%)
FB   235.29 (-0.95%)
GOOGL   1,469.40 (+1.90%)
AMZN   2,898.91 (+0.70%)
NVDA   385.84 (+1.22%)
MU   50.25 (+1.11%)
GE   6.88 (+1.93%)
TSLA   1,206.81 (+7.79%)
AMD   52.37 (-0.40%)
T   30.22 (+1.04%)
F   6.10 (+2.01%)
GILD   76.90 (+1.10%)
DIS   113.33 (+0.27%)
NFLX   479.34 (-1.30%)
BA   182.74 (+1.34%)
MSFT   207.28 (+1.26%)
FB   235.29 (-0.95%)
GOOGL   1,469.40 (+1.90%)
AMZN   2,898.91 (+0.70%)
NVDA   385.84 (+1.22%)
MU   50.25 (+1.11%)
GE   6.88 (+1.93%)
TSLA   1,206.81 (+7.79%)
AMD   52.37 (-0.40%)
T   30.22 (+1.04%)
F   6.10 (+2.01%)
GILD   76.90 (+1.10%)
DIS   113.33 (+0.27%)
NFLX   479.34 (-1.30%)
BA   182.74 (+1.34%)
MSFT   207.28 (+1.26%)
FB   235.29 (-0.95%)
GOOGL   1,469.40 (+1.90%)
AMZN   2,898.91 (+0.70%)
NVDA   385.84 (+1.22%)
MU   50.25 (+1.11%)
GE   6.88 (+1.93%)
TSLA   1,206.81 (+7.79%)
AMD   52.37 (-0.40%)
T   30.22 (+1.04%)
F   6.10 (+2.01%)
GILD   76.90 (+1.10%)
DIS   113.33 (+0.27%)
NFLX   479.34 (-1.30%)
BA   182.74 (+1.34%)
MSFT   207.28 (+1.26%)
FB   235.29 (-0.95%)
GOOGL   1,469.40 (+1.90%)
AMZN   2,898.91 (+0.70%)
NVDA   385.84 (+1.22%)
MU   50.25 (+1.11%)
GE   6.88 (+1.93%)
TSLA   1,206.81 (+7.79%)
AMD   52.37 (-0.40%)
T   30.22 (+1.04%)
F   6.10 (+2.01%)
GILD   76.90 (+1.10%)
DIS   113.33 (+0.27%)
NFLX   479.34 (-1.30%)
BA   182.74 (+1.34%)
Log in

OTCMKTS:MXDHFMDxHealth Stock Price, Forecast & News

$0.95
0.00 (0.00 %)
(As of 07/2/2020 08:47 AM ET)
Add
Compare
Today's Range
$0.95
Now: $0.95
$0.95
50-Day Range
$0.90
MA: $0.93
$0.95
52-Week Range
$0.65
Now: $0.95
$1.49
VolumeN/A
Average Volume25 shs
Market Capitalization$67.00 million
P/E RatioN/A
Dividend YieldN/A
Beta1.29
MDxHealth SA operates as a molecular diagnostics company in Germany, the Netherlands, Poland, the United States, rest of European Union, and internationally. The company develops and commercializes epigenetic and other molecular tests for cancer assessment and the personalized treatment of patients. Its tests are based on genetic, epigenetic (methylation) and other molecular technologies, and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of response to a specific therapy. The company's product pipeline includes tests for prostate, bladder, kidney, cervical, and brain cancers. Its products include ConfirmMDx, a tissue-based epigenetic test for prostate cancer; SelectMDx, a urine-based mRNA test for prostate cancer; and AssureMDx bladder cancer detection test for patients with unresolved hematuria. The company's preclinical development products comprise InformMDx, a tissue-based gene expression panel for prostate cancer; SelectMDx assay to a point of care testing platform; and MonitorMDx, a blood-based test for prostate cancer. It has collaboration agreement with 3D Signatures Inc. to evaluate prognostic test candidate for prostate cancer. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was founded in 2003 and is headquartered in Herstal, Belgium.
Read More
MDxHealth logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.55 out of 5 stars


Industry, Sector and Symbol

Industry Private households
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:MXDHF
Previous SymbolNASDAQ:MXDHF
CUSIPN/A
CIKN/A
Phone32042577021

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$11.78 million
Book Value$0.33 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap$67.00 million
Next Earnings DateN/A
OptionableNot Optionable

Receive MXDHF News and Ratings via Email

Sign-up to receive the latest news and ratings for MXDHF and its competitors with MarketBeat's FREE daily newsletter.

MDxHealth (OTCMKTS:MXDHF) Frequently Asked Questions

How has MDxHealth's stock been impacted by COVID-19 (Coronavirus)?

MDxHealth's stock was trading at $1.10 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, MXDHF shares have decreased by 13.6% and is now trading at $0.95. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of MDxHealth?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MDxHealth in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for MDxHealth.

Has MDxHealth been receiving favorable news coverage?

News articles about MXDHF stock have trended very negative on Thursday, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. MDxHealth earned a news impact score of -3.3 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news about MDxHealth.

Who are some of MDxHealth's key competitors?

Who are MDxHealth's key executives?

MDxHealth's management team includes the following people:
  • Mr. Michael K. McGarrity, CEO & Director (Age 56)
  • Mr. Kurt Schmidt, Exec. VP of Fin. & Interim CFO (Age 58)
  • Dr. Wim Van Criekinge, Chief Scientific Officer (Age 47)
  • Mr. Joseph Sollee, Chief Compliance Officer, Exec. VP of Corp. Devel. & Gen. Counsel (Age 54)
  • Mr. Jean-Marc Roelandt, CFO & Exec. VP (Leave of Absence) (Age 54)

What is MDxHealth's stock symbol?

MDxHealth trades on the OTCMKTS under the ticker symbol "MXDHF."

How do I buy shares of MDxHealth?

Shares of MXDHF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is MDxHealth's stock price today?

One share of MXDHF stock can currently be purchased for approximately $0.95.

How big of a company is MDxHealth?

MDxHealth has a market capitalization of $67.00 million and generates $11.78 million in revenue each year. The company earns $-43,100,000.00 in net income (profit) each year or ($0.53) on an earnings per share basis.

What is MDxHealth's official website?

The official website for MDxHealth is www.mdxhealth.com.

How can I contact MDxHealth?

MDxHealth's mailing address is CAP Business Center Rue d`Abhooz 31, Herstal C9, 4040. The company can be reached via phone at 32042577021 or via email at [email protected]

This page was last updated on 7/2/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.